Nobuta Lab

Oligodendrocytes are the myelinating glia cells of the brain, allowing fast conduction of action potentials among neurons, thus imperative for proper neurological functions. The major goal of the research in the Nobuta lab is to develop regenerative therapies for human oligodendrocyte disorders such as leukodystrophies, multiple sclerosis, and white matter injury associated with premature birth. The lab takes two approaches to achieve this goal: 1) gaining fundamental knowledge in human oligodendrocyte development extracting data directly from human cells and tissues, and 2) engineering transplantable human oligodendrocytes by direct lineage conversion.

CABM 223
The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation
October 3, 2025
The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation
Acta Neuropathologica Communications

Read More › about The mGluR5 agonist CHPG enhances human oligodendrocyte differentiation

Generation of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion
June 24, 2022
Generation of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion
Devlopment Journal

Read More › about Generation of functional human oligodendrocytes from dermal fibroblasts by direct lineage conversion